These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36239840)

  • 21. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary surgery for breast cancer: past, present, and future.
    Noguchi M; Inokuchi M; Noguchi M; Morioka E; Ohno Y; Kurita T
    Breast Cancer; 2021 Jan; 28(1):9-15. PubMed ID: 33165758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes.
    Joo JH; Kim SS; Son BH; Ahn SD; Jung JH; Choi EK; Ahn SH; Lee JW; Kim HJ; Ko BS
    Cancer Res Treat; 2019 Jul; 51(3):1011-1021. PubMed ID: 30322228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliable Location of Upper Extremity Lymphatic Channels for Use in Immediate Lymphatic Reconstruction.
    Wainwright D; Weinstein B; Le NK; Parikh J; Panetta NJ
    Ann Plast Surg; 2023 Jun; 90(6S Suppl 4):S391-S394. PubMed ID: 37332210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of axillary surgery on outcome of clinically node positive breast cancer treated with neoadjuvant chemotherapy.
    Dux J; Habibi M; Malik H; Jacobs L; Wright PA; Lange J; Camp M; O'Donnell M; Sun B; Tran HT; Euhus D
    Breast Cancer Res Treat; 2023 Nov; 202(2):267-273. PubMed ID: 37531016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
    Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
    Trials; 2013 Apr; 14():111. PubMed ID: 23782712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
    Seyednejad N; Kuusk U; Wiseman SM
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional axillary dissection based on lymphatic drainage for breast cancer: a single center randomized clinical trial].
    Yuan QQ; Hou JX; Zhou R; Zou SQ; Wu GS
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(32):2531-2536. PubMed ID: 34407579
    [No Abstract]   [Full Text] [Related]  

  • 33. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach.
    Johnson AR; Kimball S; Epstein S; Recht A; Lin SJ; Lee BT; James TA; Singhal D
    Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S234-S241. PubMed ID: 30855393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary lymph node dissection in the era of immediate lymphatic reconstruction: Considerations for the breast surgeon.
    Mele A; Fan B; Pardo J; Emhoff I; Beight L; Serres SK; Singhal D; Magrini L; James TA
    J Surg Oncol; 2021 Mar; 123(4):842-845. PubMed ID: 33524160
    [No Abstract]   [Full Text] [Related]  

  • 36. Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study.
    Lee J; Jung JH; Kim WW; Kang B; Keum H; Chae YS; Lee SJ; Park JY; Park NJ; Jung TD; Park HY
    Ann Surg Oncol; 2023 Aug; 30(8):4669-4677. PubMed ID: 36828929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.
    Guenther JM; Hansen NM; DiFronzo LA; Giuliano AE; Collins JC; Grube BL; O'Connell TX
    Arch Surg; 2003 Jan; 138(1):52-6. PubMed ID: 12511150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.